Immunohistochemical study of ACTH and α-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture

Journal of Dermatology

Volumn 26, Issue 8, 1999, Pages 502-506

  Ichimiya, Makoto ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenocorticotrophin (ACTH); Vitiligo; melanocyte stimulating hormone ( MSH)

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; METHARMON F; SEX HORMONE; THYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; ORAL DRUG ADMINISTRATION; SKIN DISEASE; TREATMENT OUTCOME; VITILIGO;

EID: 0032857439     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02035.x     Document Type: Article

References (21)

1. Bystryn JC: Immune mechanisms in vitiligo, Immunol Series, 46: 447-473, 1989.
2. Naughton G, Eisinger M, Bystryn JC: Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation, J Invest Dermatol, 81: 540-542, 1983.
3. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M: High frequency of thyroid dysfunction in patients with vitiligo, Acta Derm Venereol, 74: 120-123, 1994.
4. Anthony N, Harry L, Richard B: Vitiligo, in: Andrew's Disease of the Skin, WB Saunders Company, Philadelphia, 1982, ed 7, pp 1057-1059.
5. Drake LA, Dinehart SM, Farmer ER, et al: Guidelines of care for vitiligo, J Am Acad Dermatol, 35: 620-626, 1996.
6. Pasricha JS, Khaitan BK: Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease, Internat'l J Dermatol, 32: 753-757, 1993.
7. Geraldez CB, Gutierrez GT: A clinical trial of clobetasol propionate in Filipino vitiligo patients, Clinical Therapy, 9: 474-482, 1987.
8. Kahn AM, Cohen MJ: Vitiligo: Treatment by dermabrasion and epithelial sheet grafting, J Am Acad Dermatol, 33: 646-648, 1995.
9. Olsson MJ, Juhlin L: Transplantation of melanocytes in vitiligo, Br J Dermatol, 132: 587-591, 1995.
10. Muto M, Furumoto H, Ohmura A, Asagami C: Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture, J Dermatol, 22: 770-772, 1995.
11. Thody AJ, Ridley K, Penny RJ, Chalmers R, Fisher C, Shuster S: MSH peptides are present in mammalian skin, Peptides, 4: 813-816, 1983.
12. Slominski A, Paus R, Wortsman J: On the potential role of proopiomelanocortin in skin physiology and pathology, Mol Cell Endocrinol, 93: C1-C6, 1993.
13. Lunec J, Pieron C, Sherbet GV, Thody AJ: Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells, Pathobiology, 58: 193-197, 1990.
14. Yashimoto S, Fujita T: Relationship between clinical effects of postmenopausal women with climacteric symptoms. Hormone and Clinic, 31: 815-822, 1983. (in Japanese)
15. Claudy AL, Perrot JL: Hyperpigmentation induced by UVB at the application site of estradiol, Dermatologica, 181: 154-155, 1990.
16. Ranson N, Posen S, Mason R: Human melanocyte as a target tissue for hormone: In vitro studies with 1α-25 dihydroxyvitamine D3, melanocyte stimulating hormone and estradiol, J Invest Dermatol, 91: 593-598, 1998.
17. Wakamatsu K, Graham A, Cook D, Thody AJ: Characteristation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor, Pigment Cell Res, 10: 288-297, 1997.
18. Seidah NG, Day R, Marcinkiewicz M, Chretien M: Mammalian paired basic amino acid convertases of prohormones and proproteins, Ann NY Acad Sci, 680: 135-146, 1993.
19. Lunec J, Pieron C, Sherbet GV, Thody AJ: Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells, Pathobiology, 58: 193-197, 1990.
20. Chakraborty AK, Funasaka Y, Slominski A: Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: Regulation by ultraviolet B, Biochemica et Biophysica Acta, 1313: 130-138, 1996.
21. Schauer EF, Trautlinger A, Kock A: Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes, J Clin Invest, 93: 2258-2262, 1994.